New policies weakening IP innovation incentives: report

27-11-2018

New policies weakening IP innovation incentives: report

erhui1979 / iStockphoto.com

Despite the importance of IP rights to biotech and biopharma innovation, recent decisions and new policies are weakening and reducing the scope of IP-based incentives, according to a report.


Pugatch Consilium, BIO, Biotechnology Innovation Organization, innovation, regulation, SPC, SPC waiver, biotech

LSIPR